Novilytic
PrivateLast Round
Early Funding
Dec 15, 2025
Total Funding Raised
$5.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Novilytic is a biotechnology and nanotechnology company that has developed a platform to monitor the quality of lifesaving medicines in biopharmaceutical manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novilytic Comparables
Compare Novilytic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RedShift BioAnalytics | 77% | |
| Thermo Fisher Scientific Inc. | 73% | |
| Gator Bio | 71% |
Novilytic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 15, 2025 | ||||
| Grant | Nov 19, 2025 | ||||
| Accelerator | Jun 24, 2025 | ||||
| Seed | May 3, 2022 | ||||
| Early Funding | Apr 13, 2021 | ||||
Grant | Jul 16, 2020 |
Key People
Founding team and executive leadership
Novilytic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed |
| NIH RADx | Grant |
| Purdue Innovates Ventures | Seed |
| Purdue Foundry | Seed |
| BioTools Innovator | Grant, Accelerator |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 89% MoM, reaching 3K.
- Nov 19, 2025
$10K grant received from BioTools Innovator.
Novilytic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Novilytic's valuation, stock price, and market status.
Is Novilytic a public or private company?
Novilytic is a private company.
What is the current stock price of Novilytic?
Novilytic is a private company, so its shares have no public market price. Caplight tracks Novilytic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novilytic worth (valuation)?
Valuation information for Novilytic is not publicly available.
Can I buy Novilytic stock?
Novilytic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novilytic's last funding round?
Novilytic's most recent funding round was Early Funding on December 15, 2025.
Who are the main investors in Novilytic?
Key investors in Novilytic include Purdue Research Foundation, Elevate Ventures, NIH RADx, Purdue Innovates Ventures, Purdue Foundry.
Will Novilytic IPO soon?
No public IPO plans have been announced for Novilytic.
How can I track Novilytic secondary market activity?
Caplight tracks bids, offers, and trades in Novilytic's shares on secondary markets.